Skip to main content
Erschienen in: BMC Surgery 1/2015

Open Access 01.12.2015 | Research article

Outcome after surgery for acute right-sided colonic ischemia without feasible vascular intervention: a single center experience of 58 patients over 6 years

verfasst von: Samuel A Käser, Tara C Müller, Anna Guggemos, Ulrich Nitsche, Christoph Späth, Christoph A Maurer, Klaus-Peter Janssen, Jörg Kleeff, Helmut Friess, Dirk Wilhelm, Franz G Bader

Erschienen in: BMC Surgery | Ausgabe 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

The predilection site of non-occlusive mesenteric ischemia is the right-sided colon. Surgical exploration followed by segmental bowel resection and primary anastomosis or ileostomy is recommended, if vascular interventions are not feasible and conservative treatment fails. We assessed the outcome of patients in this life-threatening condition.

Methods

From a prospective database 58 patients with urgent surgery for acute right-sided colonic ischemia without feasible vascular intervention (as a surrogate for non-occlusive mesenteric ischemia) were identified. Retrospectively the patients’ characteristics, reason for ischemia, extent of resection, rate of ileostomy creation, 30 day and one year mortality, and rate of ileostomy-reversal at one year postoperative were assessed.

Results

Radiologically mesenteric arteriosclerotic disease was present in 54% of the patients. Vaso-occlusive mesenteric disease was suspected in 15% of the patients, but not confirmed intra-operatively. Ten patients underwent (extended) right-sided hemicolectomy with primary anastomosis (30-days mortality 20%, 1-year mortality 30%). Sixteen patients had (extended) right-sided hemicolectomy with creation of an ileostomy (30-days mortality 44%, 1-year mortality 86%, ostomy reversal in one patient). Twenty-five patients had (sub-) total colectomy with ileostomy creation (30-days mortality 60%, 1-year mortality 72%, ostomy reversal in two patients). Seven patients had exploration only (30-days mortality 86%, 1-year mortality 86%). Overall, the 30-days mortality-rate was 52% and the 1-year mortality-rate was 70%. Only 7% of the patients requiring an ostomy experienced ostomy-reversal.

Conclusions

Patients with urgent surgery for acute right-sided colonic ischemia without feasible vascular intervention have a very high short and long-term mortality. The rate of ostomy-reversal is very low.
Hinweise

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Study conception and design: SAK, AG; Acquisition of data: SAK AG; Analysis and interpretation of data: SAK, TCM, AG, UN, CS, CAM, KPJ, HF, JK, DW, FGB; Drafting of manuscript: SAK, FGB; Critical revision of manuscript: SAK, TCM, AG, UN, CS, CAM, KPJ, HF, JK, DW, FGB. All authors have read and approved the final version of the manuscript.

Background

Non-occlusive mesenterial ischemia (NOMI) is a rare but life-threatening condition caused by severe hypotension in the critically ill. It often occurs after myocardial infarction, after cardio-vascular surgery and due to hypovolemia after hemodialysis [1-3]. Furthermore NOMI is a rare adverse event of medication with beta-blockers or digitalis [4,5]. The incidence of NOMI increases with age [2]. NOMI is about five times less common than acute bowel infarction caused by vascular occlusion of the superior or inferior mesenteric artery with its distinct morphological patterns [6-8].
The predilection site of NOMI is the right-sided colon [1]. However, as arteriosclerotic mesenteric disease is found very often in patients at risk for NOMI and the results of imaging and the intraoperative findings regarding occlusion of branches of the superior mesenteric artery are often equivocal, it is difficult to distinguish NOMI from bowel infarction caused by vascular occlusion.
Other entities with bowel infarction to be ruled out are ischemic colitis (rarely requiring surgical therapy, without predilection site) [9], venous mesenteric infarction [10], infarction due to strangulation ileus [11] or bowel ischemia due to local compression [12]. However, these entities are diagnosed by histological examination of the resected specimen.
Early diagnosis of NOMI remains a challenge as symptoms are often non-specific [13]. If acute mesenteric ischemia is suspected, the diagnostic method of choice is multi-detector row computed tomography with intravascular contrast enhancement with the possibility to detect alterations of the colonic wall [7]. Diagnostic laparoscopy could be a valuable option, although the estimation of bowel viability by means of laparoscopy is limited [14]. Some authors recommend conventional intra-arterial angiography with its possibility of intervention [15]. If NOMI is diagnosed early, a conservative treatment with prostaglandin infusion is an option [15,16]. However, bowel resection is often required as bowel infarction is already present in most cases at the time NOMI is diagnosed [13]. Primary anastomosis is only recommended if systemic conditions have improved [16] and most cases need an ileostomy without primary anastomosis. As an option, some authors recommend primary anastomosis with planned second look in patients with acute right-sided colonic ischemia in absence of peritonitis [14]. In small case series this planned second look has been successfully done laparoscopically [17], but as mentioned above surgeons have to consider that the estimation of bowel viability by means of laparoscopy is limited [14]. Another possibility could be damage control surgery with abdominal vacuum and delayed bowel reconstruction as proposed for perforated diverticulitis Hinchey III/IV [18].
However, due to low incidence of NOMI the knowledge about this disease is only based on small case series [19]. Furthermore little is known about the optimal surgical treatment and outcome of patients with this rare but life-threatening disease.
As it was not possible to unequivocally distinguish NOMI from mesenterial infarction caused by occlusion of branches of the superior mesenteric artery, we assessed the short and long-term outcome and especially the rate of ostomy reversal in patients with acute right-sided colonic ischemia without feasible vascular intervention as a surrogate for NOMI.

Methods

Between January 2007 and January 2013 a total of 70 patients were identified in the institution’s prospectively maintained colorectal database, who had urgent surgery for acute right-sided colonic ischemia without feasible vascular intervention as judged by a senior interventional radiologist.
Patients with exploration only, with right-hemicolectomy or (sub-)total colectomy and histopathological confirmation of ischemia were included. Patients with missing histology despite resection (n = 2), toxic megacolon and/or pure hemorrhagic infarction (n = 9), and amyloidosis (n = 1) were excluded.
Thus a total of 58 patients remained for analysis. These were classified into the following groups according to the surgical treatment: (extended) right-sided hemicolectomy with primary anastomosis; (extended) right-sided hemicolectomy with creation of an ostomy; (sub-) total colectomy with ostomy creation; exploration only.
An overview of the study methodology is shown in Figure 1.
Patients’ characteristics, reason for ischemia, extent of resection, creation of ostomy versus primary anastomosis, 30 day mortality, duration of hospital stay of the patients surviving 30-days, rate of ostomy reversal, and 1 year mortality were assessed.
Statistics: Results are expressed as median and range. Pearson’s chi square test was used for categorical data. The Kruskal-Wallis test was used for continuous variables. Significance was set at the p < 0.05 level (two-sided).

Ethics statement

The present study is a retrospective observational study without any potential harm for patients. It is based on a prospectively maintained colorectal database. A statement by the responsible ethics committee allows the study group to maintain this prospectively maintained database on patients for scientific research (Ethikkommission der Fakultät für Medizin der Technischen Universität München, Nr. 1926/07).

Results

Ten patients had (extended) right-sided hemicolectomy with primary anastomosis, sixteen patients had (extended) right-sided hemicolectomy with creation of an ostomy. Twenty-five patients had (sub-) total colectomy with ostomy creation, and seven patients had exploration only due to infaust prognosis. No patient with (sub-) total colectomy had primary anastomosis done.
The groups are comparable regarding the patients’ characteristics (Table 1). The only significant difference between the groups was American Society of Anesthesiologists (ASA) score, with the worst score for the group of patients with exploration only. Of all patients who had a preoperative CT scan (n = 39), 21 patients (54%) had arteriosclerotic mesenteric disease but only n = 6 (15%) had suspected concomitant vaso-occlusive disease. However, during surgery the vaso-occlusive disease could not be confirmed.
Table 1
Patients’ characteristics
 
Total
(Extended) right-sided hemicolectomy with primary anastomosis
(Extended) right-sided hemicolectomy with creation of an ostomy
(Sub-)total colectomy with ostomy creation
Exploration only (30d mortality 86%)
p-value (comparing all fields)
Number of patients
58
10
16
25
7
 
Male gender
30
5
8
13
4
p = 0,990
Age: Median (Range)
70,3 years (31,7-95,8)
70,7 years (31,7-87,5)
70,6 years (51,3-86,6)
70,4 years (56,8-92,3)
61,7 years (60,8-83,7)
p = 0.786
Cardiovascular co-morbidities
45
8
11
21
5
p = 0,683
Suspected occlusion of the superior mesenteric artery or its branches
6/39
2/8
2/11
1/16
1/4
p = 0,584
Atherosclerotic mesenteric arterial disease
21/39
4/8
9/11
5/16
3/4
p = 0,204
Acute cardiac event prior to surgery
15
3
1
10
1
p = 0,094
Renal comorbidities
17
2
4
8
3
p = 0,736
Pulmonary comorbidities
13
1
3
6
3
p = 0,435
Hepatic comorbidities
7
1
2
3
1
p = 0,993
Neurological comorbidities
7
2
1
3
1
p = 0,768
Diabetes mellitus
8
2
0
5
1
p = 0,296
ASA-score (mean)
3.4
2.6
3.6
3.3
3.7
p = 0.010
ASA: American Society of Anesthesiologists.
No anastomotic leak occurred in the group of patients with primary anastomosis. The 30-days mortality rate of all patients together was 52%. An overview of the significantly different 30-day mortality rates of the different groups is shown in Table 2. The highest 30-day mortality rate was in the group with exploration only. The duration of hospital stay of the patients surviving 30 days (median 22 days) is also shown in Table 2. Two patients were lost to follow-up after discharge from hospital. The one-year mortality-rate of all patients together was 70%. The one-year mortality-rates were significantly different between the groups (Table 2). Ostomy reversal was done in three patients (7 % of all patients with ostomy, but in 16% of those patients with ostomy alive at 30-days postoperative (n = 19).
Table 2
Mortality, hospital stay after surgery and ostomy reversal rates
 
Total
(Extended) right-sided hemicolectomy with primary anastomosis
(Extended) right-sided hemicolectomy with creation of an ostomy
(Sub-)total colectomy with ostomy creation
Exploration only (30d mortality 86%)
p-value (comparing all fields)
Total number of patients
58
10
16
25
7
 
30-day mortality
30(52%)
2(20%)
7(44%)
15(60%)
6(86%)
p = 0,039
Median (range) of hospital stay after surgery of those patients surviving 30 days
22 days (5–220)
14.5 days (9–26)
32 days (13–96)
24 days (5–220)
40 days
p = 0,057
1-year mortality
39/56(70%)
3/10(30%)
12/14(86%)
18/25(72%)
6/7(86%)
p = 0.018
Ostomy reversal
n/A
n/A
1/9(11%)
2/10(20%)
n/A
p = 1.000
n/A: not applicable.

Discussion

We aimed to assess the surgical therapy, short and long term outcome and the rate of ostomy reversal in patients with right-sided colonic ischemia without vascular intervention.
One challenge was to draw a line between patients with NOMI and those with questionable occlusion of the branches of the superior mesenteric artery. The radiological and intraoperative findings often are equivocal regarding presence of vaso-occlusive disease. Although, the typical morphologic pattern of bowel ischemia due to complete occlusion of the superior or inferior mesenteric artery is quite distinct to right sided colonic ischemia [1] and mixing them up seems unlikely, the obstruction of a branch of the superior mesenteric artery can mimic NOMI. This is why we defined “acute right-sided colonic ischemia without feasible vascular intervention” as a surrogate for NOMI.
In a six year period we identified 58 patients who underwent surgery for acute right-sided colonic ischemia without feasible vascular intervention. Less than 20% of the patients had colonic resection and primary anastomosis. As to be expected there were significant differences in the ASA scores between the groups, reflecting the extent of disease. As to be expected patients with lower ASA scores were more likely to receive a primary anastomosis. For all patients together the 30-days mortality was 52% and 1-year mortality was as high as 70% reflecting the hazardousness of this acute right-sided colonic ischemia. There were significant different mortality rates between the groups. However, compared with historical controls these mortality rates are lower than expected [3,20]. Overall less than 10% of the ostomies were reversed, and only about 15% of those patients surviving 30 days had ostomy-reversal.
The strength of this study is the comparatively high number of patients with this rare diagnosis if compared to hitherto reported series. However, due to the retrospective nature of this study there are several limitations.
Although there was no standardized follow-up, and most of the data was collected retrospectively, only two patients (3%) were lost to follow-up.
As no anastomotic leak occurred in the group of patients with primary anastomosis, it could be argued that more patients should have had primary anastomosis with planned second look laparotomy. However, with regard to the high 30 days mortality rate of 52%, primary anastomosis with planned second-look [14] seems to be no good option in this life threatening condition of patients with acute right-sided colonic ischemia. This is confirmed by anastomotic leakage rates of 33% reported from a comparable cohort of patients [20]. However damage control surgery with abdominal vacuum and delayed bowel reconstruction as proposed for perforated diverticulitis Hinchey III/IV [18] might be a valuable option.
To confirm our results, a prospective study with standardized pre-operative work-up is required. However, it would be a challenge to run such a study as NOMI has a very low incidence and patients with NOMI often present with nonspecific symptoms and signs. Last but not least there would be ethical concerns to perform such a study in patients with this life-threatening disease with a potentially disturbance of consciousness.

Conclusion

Patients who need urgent surgery for acute right-sided colonic ischemia without feasible vascular intervention have a very high short and long-term mortality probably due to their multiple and severe underlying diseases. Less than 10% of the constructed ileostomies are reversed.
The present is a true retrospective observational study. Single patients cannot be identified based on the data provided. Thus, there is no potential harm for patients. The 1-year mortality rate was 70%. Furthermore two patients were lost to follow-up. These are the reasons why written informed consent could not be obtained from the majority of the patients. However, we feel that from an ethical point of view, this should not hinder publication of the results of this study.

Acknowledgement

The study was funded by the Klinikum rechts der Isar der Technischen Universität München. There was no additional funding.
We thank all the medical students who maintain the prospective colorectal database.
The results of this study were presented as an oral presentation at the annual meeting of the Swiss Surgical Society 2014.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

Study conception and design: SAK, AG; Acquisition of data: SAK AG; Analysis and interpretation of data: SAK, TCM, AG, UN, CS, CAM, KPJ, HF, JK, DW, FGB; Drafting of manuscript: SAK, FGB; Critical revision of manuscript: SAK, TCM, AG, UN, CS, CAM, KPJ, HF, JK, DW, FGB. All authors have read and approved the final version of the manuscript.
Literatur
1.
Zurück zum Zitat Quiroga B, Verde E, Abad S, Vega A, Goicoechea M, Reque J, et al. Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis. J Surg Res. 2013;180:51–5.CrossRefPubMed Quiroga B, Verde E, Abad S, Vega A, Goicoechea M, Reque J, et al. Detection of patients at high risk for non-occlusive mesenteric ischemia in hemodialysis. J Surg Res. 2013;180:51–5.CrossRefPubMed
2.
Zurück zum Zitat Acosta S, Ogren M, Sternby NH, Bergqvist D, Bjorck M. Fatal nonocclusive mesenteric ischaemia: population-based incidence and risk factors. J Intern Med. 2006;259:305–13.CrossRefPubMed Acosta S, Ogren M, Sternby NH, Bergqvist D, Bjorck M. Fatal nonocclusive mesenteric ischaemia: population-based incidence and risk factors. J Intern Med. 2006;259:305–13.CrossRefPubMed
3.
Zurück zum Zitat Kramer SC, Gorich J, Oertel F, Scheld H, Heindel W. Non-occlusive mesenteric ischemia. Rofo. 2003;175:1177–83.CrossRefPubMed Kramer SC, Gorich J, Oertel F, Scheld H, Heindel W. Non-occlusive mesenteric ischemia. Rofo. 2003;175:1177–83.CrossRefPubMed
4.
Zurück zum Zitat Weil J, Sen Gupta R, Herfarth H. Nonocclusive mesenteric ischemia induced by digitalis. Int J Colorectal Dis. 2004;19:277–80.CrossRefPubMed Weil J, Sen Gupta R, Herfarth H. Nonocclusive mesenteric ischemia induced by digitalis. Int J Colorectal Dis. 2004;19:277–80.CrossRefPubMed
5.
Zurück zum Zitat Pettei MJ, Levy J, Abramson S. Nonocclusive mesenteric ischemia associated with propranolol overdose: implications regarding splanchnic circulation. J Pediatr Gastroenterol Nutr. 1990;10:544–7.CrossRefPubMed Pettei MJ, Levy J, Abramson S. Nonocclusive mesenteric ischemia associated with propranolol overdose: implications regarding splanchnic circulation. J Pediatr Gastroenterol Nutr. 1990;10:544–7.CrossRefPubMed
6.
Zurück zum Zitat van den Heijkant TC, Aerts BA, Teijink JA, Buurman WA, Luyer MD. Challenges in diagnosing mesenteric ischemia. World J Gastroenterol. 2013;19:1338–41.CrossRefPubMedPubMedCentral van den Heijkant TC, Aerts BA, Teijink JA, Buurman WA, Luyer MD. Challenges in diagnosing mesenteric ischemia. World J Gastroenterol. 2013;19:1338–41.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010;23:4–8.CrossRefPubMed Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010;23:4–8.CrossRefPubMed
8.
Zurück zum Zitat Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2002;12:1179–87.CrossRefPubMed Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol. 2002;12:1179–87.CrossRefPubMed
9.
Zurück zum Zitat Glauser PM, Wermuth P, Cathomas G, Kuhnt E, Kaser SA, Maurer CA. Ischemic colitis: clinical presentation, localization in relation to risk factors, and long-term results. World J Surg. 2011;35:2549–54.CrossRefPubMed Glauser PM, Wermuth P, Cathomas G, Kuhnt E, Kaser SA, Maurer CA. Ischemic colitis: clinical presentation, localization in relation to risk factors, and long-term results. World J Surg. 2011;35:2549–54.CrossRefPubMed
10.
Zurück zum Zitat Kaser SA, Glauser PM, Maurer CA. Venous small bowel infarction: intraoperative laser Doppler flowmetry discriminates critical blood supply and spares bowel length. Case Rep Med. 2012;2012:195926.CrossRefPubMedPubMedCentral Kaser SA, Glauser PM, Maurer CA. Venous small bowel infarction: intraoperative laser Doppler flowmetry discriminates critical blood supply and spares bowel length. Case Rep Med. 2012;2012:195926.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Miyauchi T, Kuroda T, Nisioka M, Hashimoto T, Kasamatu T, Kuratate S, et al. Clinical study of strangulation obstruction of the small bowel. J Med Invest. 2001;48:66–72.PubMed Miyauchi T, Kuroda T, Nisioka M, Hashimoto T, Kasamatu T, Kuratate S, et al. Clinical study of strangulation obstruction of the small bowel. J Med Invest. 2001;48:66–72.PubMed
12.
Zurück zum Zitat Kaser SA, Willi N, Maurer CA. Mandatory Resection of Strangulation Marks in Small Bowel Obstruction? World J Surg. 2014;38:11–5.CrossRefPubMed Kaser SA, Willi N, Maurer CA. Mandatory Resection of Strangulation Marks in Small Bowel Obstruction? World J Surg. 2014;38:11–5.CrossRefPubMed
13.
Zurück zum Zitat Howard TJ, Plaskon LA, Wiebke EA, Wilcox MG, Madura JA. Nonocclusive mesenteric ischemia remains a diagnostic dilemma. Am J Surg. 1996;171:405–8.CrossRefPubMed Howard TJ, Plaskon LA, Wiebke EA, Wilcox MG, Madura JA. Nonocclusive mesenteric ischemia remains a diagnostic dilemma. Am J Surg. 1996;171:405–8.CrossRefPubMed
14.
Zurück zum Zitat Hanisch E, Schmandra TC, Encke A. Surgical strategies – anastomosis or stoma, a second look – when and why? Langenbecks Arch Surg. 1999;384:239–42.CrossRefPubMed Hanisch E, Schmandra TC, Encke A. Surgical strategies – anastomosis or stoma, a second look – when and why? Langenbecks Arch Surg. 1999;384:239–42.CrossRefPubMed
15.
Zurück zum Zitat Ernst S, Luther B, Zimmermann N, Bohner H, Wilke R, Feindt P, et al. Current diagnosis and therapy of non-occlusive mesenteric ischemia. Rofo. 2003;175:515–23.CrossRefPubMed Ernst S, Luther B, Zimmermann N, Bohner H, Wilke R, Feindt P, et al. Current diagnosis and therapy of non-occlusive mesenteric ischemia. Rofo. 2003;175:515–23.CrossRefPubMed
16.
Zurück zum Zitat Mitsuyoshi A, Obama K, Shinkura N, Ito T, Zaima M. Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E(1). Ann Surg. 2007;246:229–35.CrossRefPubMedPubMedCentral Mitsuyoshi A, Obama K, Shinkura N, Ito T, Zaima M. Survival in nonocclusive mesenteric ischemia: early diagnosis by multidetector row computed tomography and early treatment with continuous intravenous high-dose prostaglandin E(1). Ann Surg. 2007;246:229–35.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Yanar H, Taviloglu K, Ertekin C, Ozcinar B, Yanar F, Guloglu R, et al. Planned second-look laparoscopy in the management of acute mesenteric ischemia. World J Gastroenterol. 2007;13:3350–3.CrossRefPubMedPubMedCentral Yanar H, Taviloglu K, Ertekin C, Ozcinar B, Yanar F, Guloglu R, et al. Planned second-look laparoscopy in the management of acute mesenteric ischemia. World J Gastroenterol. 2007;13:3350–3.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Kafka-Ritsch R, Birkfellner F, Perathoner A, Raab H, Nehoda H, Pratschke J, et al. Damage control surgery with abdominal vacuum and delayed bowel reconstruction in patients with perforated diverticulitis Hinchey III/IV. J Gastrointest Surg. 2012;16:1915–22.CrossRefPubMed Kafka-Ritsch R, Birkfellner F, Perathoner A, Raab H, Nehoda H, Pratschke J, et al. Damage control surgery with abdominal vacuum and delayed bowel reconstruction in patients with perforated diverticulitis Hinchey III/IV. J Gastrointest Surg. 2012;16:1915–22.CrossRefPubMed
19.
Zurück zum Zitat Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004;91:17–27.CrossRefPubMed Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. 2004;91:17–27.CrossRefPubMed
20.
Zurück zum Zitat Ward D, Vernava AM, Kaminski DL, Ure T, Peterson G, Garvin P, et al. Improved outcome by identification of high-risk nonocclusive mesenteric ischemia, aggressive reexploration, and delayed anastomosis. Am J Surg. 1995;170:577–80. discussion 580–571.CrossRefPubMed Ward D, Vernava AM, Kaminski DL, Ure T, Peterson G, Garvin P, et al. Improved outcome by identification of high-risk nonocclusive mesenteric ischemia, aggressive reexploration, and delayed anastomosis. Am J Surg. 1995;170:577–80. discussion 580–571.CrossRefPubMed
Metadaten
Titel
Outcome after surgery for acute right-sided colonic ischemia without feasible vascular intervention: a single center experience of 58 patients over 6 years
verfasst von
Samuel A Käser
Tara C Müller
Anna Guggemos
Ulrich Nitsche
Christoph Späth
Christoph A Maurer
Klaus-Peter Janssen
Jörg Kleeff
Helmut Friess
Dirk Wilhelm
Franz G Bader
Publikationsdatum
01.12.2015
Verlag
BioMed Central
Erschienen in
BMC Surgery / Ausgabe 1/2015
Elektronische ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-015-0018-0

Weitere Artikel der Ausgabe 1/2015

BMC Surgery 1/2015 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.